Atlas Trials

Safety, Tolerability and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Participants With Worsening Heart Failure

Clinical trial NCT03292653 · TERMINATED

Trial details

NCT number
NCT03292653
Sponsor
Lexicon Pharmaceuticals
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiac Failure Aggravated
Start date
2017-12-04
Primary completion
2019-08-17
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.